Literature DB >> 19619121

Effects of pH and arginine on the solubility and stability of a therapeutic protein (Fibroblast Growth Factor 20): relationship between solubility and stability.

Haripada Maity1, Cyrus Karkaria, Juan Davagnino.   

Abstract

The purpose of this study was to dramatically enhance the solubility (> 400 fold) and stability of a therapeutic protein (Fibroblast Growth Factor 20) and to perform detailed biophysical characterization for the optimization of its formulation. The solubility of FGF-20 strongly depends on pH, arginine concentration and anions present in a buffer system. In the absence and presence of arginine, solubility was higher at lower pH (5 < or = pH < or = 6) and then decreased steadily with a minimum solubility at around pH 6.3 and plateaus at around pH 7.5 respectively. For a given pH, the protein was most soluble in arginine-sulfate. The solubility of FGF-20 increases with an increase in arginine-sulfate concentration for a given pH. However, a salting out effect was observed at higher arginine-sulfate concentration. Polysorbate-80 did not have any striking effect on solubility and no effect on thermal stability, but it significantly prevented the loss of protein under agitated conditions. Thermal stability of FGF-20 measured by DSC was increased with an increase in arginine-sulfate concentration (at least up to 0.5M). A sturdy dependence of thermal stability on pH was observed with about a 15 degrees C increase in T(m) (melting temperature) at pH 7.0 in comparison to pH 5.0. From the DSC data, approximate stability curves were generated and cold denaturation temperatures were predicted. Denaturant induced unfolding studies provided better insight of FGF-20 in different solution conditions in terms of structure and stability than the DSC data. An inverse relationship of solubility and thermal stability was observed in the pH range of 5.0 to 8.5 at a fixed arginine concentration and is consistent with Linderstrom-Lange's smeared model. A direct correlation between solubility and thermal stability was observed at different arginine concentrations for a fixed pH. The effect of arginine on the solubility and stability of FGF-20 was dominated by the preferential binding interaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19619121     DOI: 10.2174/138920109789069297

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  9 in total

1.  Probing of L-arginine as an additive for the temperature-induced aggregation of veterinary growth hormones: fluorescence study.

Authors:  Andrejus Cirkovas; Jolanta Sereikaite
Journal:  Mol Biotechnol       Date:  2011-09       Impact factor: 2.695

2.  Arginine and the Hofmeister Series: the role of ion-ion interactions in protein aggregation suppression.

Authors:  Curtiss P Schneider; Diwakar Shukla; Bernhardt L Trout
Journal:  J Phys Chem B       Date:  2011-05-13       Impact factor: 2.991

3.  Characterization and Value Assignment of a Monoclonal Antibody Reference Material, NMIJ RM 6208a, AIST-MAB.

Authors:  Tomoya Kinumi; Kazumi Saikusa; Megumi Kato; Reiko Kojima; Chieko Igarashi; Naohiro Noda; Shinya Honda
Journal:  Front Mol Biosci       Date:  2022-06-06

4.  Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs.

Authors:  K Brookes; J Cummings; A Backen; A Greystoke; T Ward; G C Jayson; C Dive
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

5.  Adsorption behavior of a human monoclonal antibody at hydrophilic and hydrophobic surfaces.

Authors:  Ruairidh G Couston; Maximilian W Skoda; Shahid Uddin; Christopher F van der Walle
Journal:  MAbs       Date:  2012-11-29       Impact factor: 5.857

6.  Effects of temperature and additives on stability and spectrum of a therapeutic fibroblast growth factor.

Authors:  Cy Zhou; X Guo; St Wang; Yp Zhu; Dz Mu
Journal:  Daru       Date:  2011       Impact factor: 3.117

7.  HaloTag is an effective expression and solubilisation fusion partner for a range of fibroblast growth factors.

Authors:  Changye Sun; Yong Li; Sarah E Taylor; Xianqing Mao; Mark C Wilkinson; David G Fernig
Journal:  PeerJ       Date:  2015-06-25       Impact factor: 2.984

8.  Development of a stable liquid formulation of live attenuated influenza vaccine.

Authors:  Jessica A White; Marcus Estrada; E Alexander Flood; Kutub Mahmood; Rajeev Dhere; Dexiang Chen
Journal:  Vaccine       Date:  2016-05-04       Impact factor: 3.641

9.  Heparin binding preference and structures in the fibroblast growth factor family parallel their evolutionary diversification.

Authors:  Yong Li; Changye Sun; Edwin A Yates; Chao Jiang; Mark C Wilkinson; David G Fernig
Journal:  Open Biol       Date:  2016-03       Impact factor: 6.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.